查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
头颈癌诊断市场报告：2030 年趋势、预测与竞争分析
市场调查报告书
商品编码
1386078

头颈癌诊断市场报告：2030 年趋势、预测与竞争分析

Head and Neck Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

头颈癌诊断的趋势和预测

到 2030 年，全球头颈癌诊断市场预计将达到 34 亿美元，2024 年至 2030 年年复合成长率为 7.1%。市场的主要驱动因素是头颈癌盛行率不断上升、获得医疗保健的机会迅速增加、人们对头颈癌体征和症状以及早期检测重要性的认识不断提高。全球头颈癌诊断市场的未来前景看好，医院、门诊手术中心和诊断中心市场存在商机。

头颈癌诊断市场洞察

Lucintel 预测诊断影像将在预测期内达到最高成长。

医院将继续成为该市场的最大细分市场，因为它们拥有更好的疾病诊断能力，并配备了最新的医疗设备和技术，为患者提供最佳的治疗。

由于拥有强大的医疗基础设施、有利的报销政策、对该疾病的高度认识以及政府对医疗保健行业发展的支持，北美在预测期内可能仍然是最大的地区。

市场规模/估计：以金额的头颈癌诊断市场规模估计（10 亿美元）。

趋势和预测分析：按细分市场和地区分類的市场趋势（2018-2023）和预测（2024-2030）。

市场区隔分析：按类型、诊断、治疗、最终用途和地区等各个细分市场估计头颈癌诊断市场规模（十亿美元）。

区域分析：北美、欧洲、亚太地区和世界其他地区头颈癌诊断市场的区域细分。

成长机会：按类型、诊断、治疗、最终用途和地区分析头颈癌诊断市场的成长机会。

策略分析：头颈癌诊断市场併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析。

常问问题

Q.1 头颈癌诊断的市场规模有多大？

到2030 年，全球头颈癌诊断市场预计将达到 34 亿美元。

Q.2 头颈癌诊断市场的成长预测如何？

答：到 2030 年，头颈癌诊断市场预计将达到 34 亿美元： 2024 年至 2030 年，全球头颈癌诊断市场预计将以 7.1% 的年复合成长率增长。Masu。

Q.3 影响头颈癌诊断市场成长的关键驱动因素有哪些？

答：这个市场的主要驱动力是头颈癌盛行率不断上升、医疗保健普及率迅速增加、人们对头颈癌体征和症状以及早期检测重要性的认识不断提高。

Q4. 头颈癌诊断市场的主要细分市场有哪些？

答：头颈癌诊断市场的前景看好，医院、门诊手术中心和诊断中心市场都有商机。

Q5. 头颈癌诊断市场的主要企业有哪些？

答：头颈癌诊断的主要企业有：

  • GE Healthcare
  • Philips
  • Siemens Healthineeer
  • Merck
  • Eli Lilly

Q6. 未来头颈癌诊断哪个领域的市场规模最大？

答：Lucintel 预测诊断影像将在预测期内达到最高成长。

Q7. 在头颈癌诊断市场中，预计未来年度哪个地区的市场规模最大？

由于强大的医疗基础设施、有利的报销政策、对疾病的高度认识以及政府对医疗保健行业发展的支持，北美在预测期内仍将是最大的地区。

Q.8 是否可以客製化报告？

答：是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

本报告回答了 11 个关键问题：

  • Q.1. 哪些细分市场最有前景和高成长机会？
  • Q.2. 哪个细分市场将以更快的速度成长？为什么？
  • Q.3. 您认为哪些地区未来会出现更快的成长，为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6. 这个市场有哪些新趋势？为什么？
  • Q.7. 市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9. 谁是这个市场的主要企业？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11. 过去年度发生了哪些类型的併购，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球头颈癌诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球头颈癌诊断市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球头颈癌诊断市场
    • 喉癌
    • 咽癌
    • 唾液腺癌
    • 唇癌和口腔癌
    • 鼻咽癌
    • 其他的
  • 全球头颈癌诊断市场（按诊断）
    • 生物筛选试验
    • 验血
    • 牙科诊断
    • 影像
    • 内视镜
  • 按治疗分類的全球头颈癌诊断市场
    • 化疗
    • 放射治疗
    • 标靶治疗
    • 外科手术
    • 其他的
  • 按最终用途分類的全球头颈癌诊断市场
    • 医院
    • 门诊手术中心
    • 诊断中心
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 按地区分類的全球头颈癌诊断市场
  • 北美头颈癌诊断市场
  • 欧洲头颈癌诊断市场
  • 亚太地区头颈癌诊断市场
  • 其他地区头颈癌诊断市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球头颈癌诊断市场成长机会（按类型）
    • 全球头颈癌诊断市场按诊断的成长机会
    • 全球头颈癌诊断市场治疗成长机会
    • 按最终用途分類的全球头颈癌诊断市场的成长机会
    • 全球头颈癌诊断市场按地区成长机会
  • 全球头颈癌诊断市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球头颈癌诊断市场的产能
    • 全球头颈癌诊断市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • GE Healthcare
  • Philips
  • Siemens Healthineeer
  • Merck
  • Eli Lilly
简介目录

Head and Neck Cancer Diagnostic Trends and Forecast

The future of the global head and neck cancer diagnostic market looks promising with opportunities in the hospital, ambulatory surgical center, and diagnostic center markets. The global head and neck cancer diagnostic market is expected to reach an estimated $3.4 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of head and neck cancer, surhing access to healthcare, and growing awareness of the signs and symptoms of head and neck cancer, as well as the importance of early detection.

A more than 150-page report is developed to help in your business decisions.

Head and Neck Cancer Diagnostic by Segment

The study includes a forecast for the global head and neck cancer diagnostic by type, diagnosis, treatment, end use, and region.

Head and Neck Cancer Diagnostic Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Laryngeal Cancer
  • Pharyngeal Cancer
  • Salivary Gland Cancer
  • Lip & Oral Cavity Cancer
  • Nasopharyngeal Cancer
  • Others

Head and Neck Cancer Diagnostic Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

  • Bioscopy Screening Tests
  • Blood Tests
  • Dental Diagnosis
  • Imaging
  • Endoscopy

Head and Neck Cancer Diagnostic Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Chemotherapy
  • Radiation Therapy
  • Targeted Therapy
  • Surgery
  • Others

Head and Neck Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others

Head and Neck Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Head and Neck Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies head and neck cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the head and neck cancer diagnostic companies profiled in this report include-

  • GE Healthcare
  • Philips
  • Siemens Healthineeer
  • Merck
  • Eli Lilly

Head and Neck Cancer Diagnostic Market Insights

Lucintel forecasts that imaging is expected to witness highest growth over the forecast period.

Within this market, hospitals will remain the largest segment because it has better disease diagnosis capabilities and also have the latest medical equipment and technology, which allows them to provide patients with the best possible care.

North America will remain the largest region during the forecast period due to the presence of a strong healthcare infrastructure, favorable reimbursement policies, high awareness about the disease, and government support for the development of the healthcare sector.

Features of the Global Head and Neck Cancer Diagnostic Market

Market Size Estimates: Head and neck cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Head and neck cancer diagnostic market size by various segments, such as by type, diagnosis, treatment, end use, and region in terms of ($B).

Regional Analysis: Head and neck cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, diagnosis, treatments, end uses, and regions for the head and neck cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the head and neck cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the head and neck cancer diagnostic market size?

Answer: The global head and neck cancer diagnostic market is expected to reach an estimated 3.4 billion by 2030.

Q.2 What is the growth forecast for head and neck cancer diagnostic market?

Answer: The global head and neck cancer diagnostic market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the head and neck cancer diagnostic market?

Answer: The major drivers for this market are increasing prevalence of head and neck cancer, surhing access to healthcare, and growing awareness of the signs and symptoms of head and neck cancer, as well as the importance of early detection.

Q4. What are the major segments for head and neck cancer diagnostic market?

Answer: The future of the head and neck cancer diagnostic market looks promising with opportunities in the hospital, ambulatory surgical center, and diagnostic center markets.

Q5. Who are the key head and neck cancer diagnostic market companies?

Answer: Some of the key head and neck cancer diagnostic companies are as follows:

  • GE Healthcare
  • Philips
  • Siemens Healthineeer
  • Merck
  • Eli Lilly

Q6. Which head and neck cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that imaging is expected to witness highest growth over the forecast period.

Q7. In head and neck cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region during the forecast period due to the presence of a strong healthcare infrastructure, favorable reimbursement policies, high awareness about the disease, and government support for the development of the healthcare sector.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the head and neck cancer diagnostic market by type (laryngeal cancer, pharyngeal cancer, salivary gland cancer, lip & oral cavity cancer, nasopharyngeal cancer, and others), diagnosis (bioscopy screening tests, blood tests, dental diagnosis, imaging, and endoscopy), treatment (chemotherapy, radiation therapy, targeted therapy, surgery, and others), end use (hospitals, ambulatory surgical centers, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Head and Neck Cancer Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Head and Neck Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Head and Neck Cancer Diagnostic Market by Type
    • 3.3.1: Laryngeal Cancer
    • 3.3.2: Pharyngeal Cancer
    • 3.3.3: Salivary Gland Cancer
    • 3.3.4: Lip & Oral Cavity Cancer
    • 3.3.5: Nasopharyngeal Cancer
    • 3.3.6: Others
  • 3.4: Global Head and Neck Cancer Diagnostic Market by Diagnosis
    • 3.4.1: Bioscopy Screening Tests
    • 3.4.2: Blood Tests
    • 3.4.3: Dental Diagnosis
    • 3.4.4: Imaging
    • 3.4.5: Endoscopy
  • 3.5: Global Head and Neck Cancer Diagnostic Market by Treatment
    • 3.5.1: Chemotherapy
    • 3.5.2: Radiation Therapy
    • 3.5.3: Targeted Therapy
    • 3.5.4: Surgery
    • 3.5.5: Others
  • 3.6: Global Head and Neck Cancer Diagnostic Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Ambulatory Surgical Centers
    • 3.6.3: Diagnostic Centers
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Head and Neck Cancer Diagnostic Market by Region
  • 4.2: North American Head and Neck Cancer Diagnostic Market
    • 4.2.2: North American Head and Neck Cancer Diagnostic Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
  • 4.3: European Head and Neck Cancer Diagnostic Market
    • 4.3.1: European Head and Neck Cancer Diagnostic Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
    • 4.3.2: European Head and Neck Cancer Diagnostic Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
  • 4.4: APAC Head and Neck Cancer Diagnostic Market
    • 4.4.1: APAC Head and Neck Cancer Diagnostic Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
    • 4.4.2: APAC Head and Neck Cancer Diagnostic Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
  • 4.5: ROW Head and Neck Cancer Diagnostic Market
    • 4.5.1: ROW Head and Neck Cancer Diagnostic Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
    • 4.5.2: ROW Head and Neck Cancer Diagnostic Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Type
    • 6.1.2: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Diagnosis
    • 6.1.3: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Treatment
    • 6.1.4: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by End Use
    • 6.1.5: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Head and Neck Cancer Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Head and Neck Cancer Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Head and Neck Cancer Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GE Healthcare
  • 7.2: Philips
  • 7.3: Siemens Healthineeer
  • 7.4: Merck
  • 7.5: Eli Lilly